Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07546357 · ClinicalTrials.gov registry record · NA
AIManage Using an AI-driven CDS and Chatbot
A NA study, sponsored by NYU Langone Health.
- Not yet
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT07546357 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 16 participants.
The verdict
NCT07546357, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The objective of this project is to define and test the GenAI-powered Clinical Decision Support (CDS) tool, AIManage, providing a broad range of incretin mimetic medication management services to optimize dose titrations. The study will take place across primary care and obesity medicine clinics at NYUH. The study is currently conducting formative data collection for tool refinement (Phase 1). Once completed, a cluster randomized controlled trial of the AIManage tool will be undertaken (Phase 2).
Interventions
- OTHER AIManage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2029-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07546357
The ClinicalTrials.gov registry entry for NCT07546357 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AIManage is the first listed.
NCT07546357 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07546357 about?
NCT07546357 is a clinical study titled "AIManage Using an AI-driven CDS and Chatbot". The objective of this project is to define and test the GenAI-powered Clinical Decision Support (CDS) tool, AIManage, providing a broad range of incretin mimetic medication management services to optimize dose titrations. The study will take place across primary care and obesity medicine clinics at ...
What is the current status of trial NCT07546357?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2026-06-01. Estimated completion is 2029-03-30.
What interventions are being tested in trial NCT07546357?
The interventions under investigation include: AIManage (OTHER).
Who is sponsoring clinical trial NCT07546357?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.